Beximco Pharmaceuticals Overview
- Year Founded
-
1976
- Status
-
Public
- Employees
-
1,223
- Stock Symbol
-
BXPHARMA
- Investments
-
3
- Share Price
-
$1.16
- (As of Wednesday Closing)
Beximco Pharmaceuticals General Information
Description
Beximco Pharmaceuticals PLC is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.
Contact Information
Website
www.beximcopharma.comCorporate Office
- 19 Dhanmondi R/A
- Road Number 7
- Dhaka, 1205
- Bangladesh
Corporate Office
- 19 Dhanmondi R/A
- Road Number 7
- Dhaka, 1205
- Bangladesh
Beximco Pharmaceuticals Stock Performance
As of 18-Nov-2026, Beximco Pharmaceuticals’s stock price is $1.16. Its current market cap is $517M with 446M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.16 | $1.17 | $0.80 - $1.27 | $517M | 446M | 570K | $0.16 |
Beximco Pharmaceuticals Financials Summary
As of 30-Jun-2026, Beximco Pharmaceuticals has a trailing 12-month revenue of $455M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 519,649 | 519,649 | 373,330 | 518,393 |
| Revenue | 454,547 | 454,547 | 402,827 | 394,808 |
| EBITDA | 102,131 | 102,131 | 97,636 | 94,492 |
| Net Income | 72,686 | 72,686 | 56,919 | 51,846 |
| Total Assets | 651,114 | 651,114 | 591,880 | 581,780 |
| Total Debt | 37,147 | 37,147 | 40,126 | 50,552 |
Beximco Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Beximco Pharmaceuticals Comparisons
Industry
Financing
Details
Beximco Pharmaceuticals Competitors (62)
One of Beximco Pharmaceuticals’s 62 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zydus Lifesciences | Corporation | Ahmedabad, India | ||||
| Popular Pharmaceuticals | Private Debt Financed | Dhaka, Bangladesh | ||||
| Medis ( Pharmaceuticals) | Corporation | Hafnarfjordur, Iceland | ||||
| Amneal Pharmaceuticals | Formerly PE-Backed | Bridgewater, NJ | ||||
| Bluefish Pharmaceuticals | Private Equity-Backed | Stockholm, Sweden |
Beximco Pharmaceuticals Patents
Beximco Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015903141-A0 | Controlled release formulations of paracetamol | Inactive | 05-Aug-2015 | ||
| AU-2016210691-A1 | Controlled release formulations of paracetamol | Inactive | 05-Aug-2015 |
Beximco Pharmaceuticals Signals
Beximco Pharmaceuticals Investments & Acquisitions (3)
Beximco Pharmaceuticals’s most recent deal was a Merger/Acquisition with Sanofi Bangladesh for . The deal was made on 10-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanofi Bangladesh | 10-Apr-2021 | Merger/Acquisition | Pharmaceuticals | ||
| Sandoz Pharmaceuticals (8 Abbreviated New Drug Applications) | 20-Feb-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Nuvista Pharma | 02-Apr-2018 | Merger/Acquisition | Pharmaceuticals |
Beximco Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Beximco Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nuvista Pharma | Dhaka, Bangladesh | 1963 |
Beximco Pharmaceuticals FAQs
-
When was Beximco Pharmaceuticals founded?
Beximco Pharmaceuticals was founded in 1976.
-
Where is Beximco Pharmaceuticals headquartered?
Beximco Pharmaceuticals is headquartered in Dhaka, Bangladesh.
-
What is the size of Beximco Pharmaceuticals?
Beximco Pharmaceuticals has 1,223 total employees.
-
What industry is Beximco Pharmaceuticals in?
Beximco Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Beximco Pharmaceuticals a private or public company?
Beximco Pharmaceuticals is a Public company.
-
What is Beximco Pharmaceuticals’s stock symbol?
The ticker symbol for Beximco Pharmaceuticals is BXPHARMA.
-
What is the current stock price of Beximco Pharmaceuticals?
As of 18-Nov-2026 the stock price of Beximco Pharmaceuticals is $1.16.
-
What is the current market cap of Beximco Pharmaceuticals?
The current market capitalization of Beximco Pharmaceuticals is $517M.
-
What is Beximco Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Beximco Pharmaceuticals is $455M.
-
Who are Beximco Pharmaceuticals’s competitors?
Zydus Lifesciences, Popular Pharmaceuticals, Medis ( Pharmaceuticals), Amneal Pharmaceuticals, and Bluefish Pharmaceuticals are some of the 62 competitors of Beximco Pharmaceuticals.
-
What is Beximco Pharmaceuticals’s annual earnings per share (EPS)?
Beximco Pharmaceuticals’s EPS for 12 months was $0.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process